Medicine and Dentistry
Human Immunodeficiency Virus
100%
Infection
36%
Cohort Analysis
35%
Severe Acute Respiratory Syndrome Coronavirus 2
35%
COVID-19
27%
Prevalence
19%
Diagnosis
16%
Diagnostic Accuracy
15%
Lipoarabinomannan
14%
Disease
13%
Cross Sectional Study
11%
Population
10%
Odds Ratio
10%
Antiretroviral Therapy
9%
Outpatient
8%
Meta-Analysis
8%
Tuberculous Meningitis
8%
Comorbidity
7%
Systematic Review
7%
Cohort Effect
6%
Mycobacterium Tuberculosis
6%
Emergency Department
6%
Atypical Mycobacterium
6%
Tuberculosis Treatment
6%
Messenger RNA
6%
Lung Tuberculosis
6%
Wart Virus
6%
Logistic Regression Analysis
6%
C Reactive Protein
5%
Prospective Cohort Study
5%
Human Immunodeficiency Virus Infection
5%
Cellular Immunity
5%
Retrospective Study
5%
Mycobacterium Tuberculosis Complex
5%
Randomized Controlled Trial
5%
Kidney Graft
5%
Urinary Tract Infection
5%
Lung
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
46%
SARS Coronavirus
33%
Infection
29%
Cohort Study
28%
Disease
21%
Prevalence
20%
Coronavirinae
11%
Placebo
11%
Lipoarabinomannan
8%
Tuberculous Meningitis
8%
Tuberculostatic Agent
8%
C Reactive Protein
8%
Prospective Cohort Study
7%
Atypical Mycobacterium
7%
Comorbidity
7%
COVID-19 Vaccine
7%
Messenger RNA
7%
Randomized Controlled Trial
7%
Immunogenicity
6%
Isoniazid
6%
Monoclonal Antibody
6%
mRNA Vaccine
5%
Lung Tuberculosis
5%
Remdesivir
5%
Drug Resistance
5%
Drug Resistant Tuberculosis
5%
Cross-Sectional Study
5%
Dexamethasone
5%
Mycobacterium Tuberculosis
5%
Common Variable Immunodeficiency
5%
Retrospective Study
5%
Antivirus Agent
5%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
47%
Human Immunodeficiency Virus
28%
Immunology
25%
COVID-19
17%
Spike
14%
Antibody Response
12%
Prevalence
11%
Omicron Coronavirus Variant
10%
Breakthrough Infection
10%
Nontuberculous mycobacteria
8%
Immune Response
6%
Adoptive Immunity
6%
Comorbidity
6%
Mycobacterium Tuberculosis Complex
6%
Mycobacterium Tuberculosis
5%
Human Immunodeficiency Virus 1
5%
Familial Mediterranean Fever
5%
Common Variable Immunodeficiency
5%
Tuberculous Meningitis
5%
Blood Plasma
5%
Humoral Immunity
5%
